Does WellCare Cover Propecia?

Why WellCare Excludes Propecia From Its Formulary

WellCare Health Plans, a Centene Corporation subsidiary operating Medicare Advantage, Medicaid managed care, and standalone Part D prescription drug plans across 25+ states, excludes Propecia and its generic equivalents from standard formulary coverage. The reason is straightforward: hair loss treatment is classified as cosmetic by the Centers for Medicare & Medicaid Services (CMS), and WellCare follows CMS formulary guidance for excluded drug categories.

How CMS Cosmetic Exclusions Work

CMS regulations under 42 CFR § 423.120 permit Part D plan sponsors to exclude drugs used for cosmetic purposes or hair growth. WellCare's formulary documents consistently list "agents for hair growth" among excluded categories [1]. This is not unique to WellCare. Every Medicare Part D plan in the United States is allowed to exclude drugs in this category, and most do.

The Brand vs. Generic Distinction Does Not Matter Here

Some patients assume that switching from brand-name Propecia to generic finasteride 1 mg will solve the coverage problem. It won't. The exclusion is indication-based, not product-based. Both the brand and generic versions of finasteride 1 mg carry the same FDA-approved indication for androgenetic alopecia and fall under the same cosmetic exclusion [2].

The situation changes when the indication changes. Finasteride 5 mg (Proscar) is FDA-approved for BPH, a medical condition. WellCare formularies generally include finasteride 5 mg on Tier 1 or Tier 2 for BPH treatment, with typical copays of $0 to $10 depending on the specific plan [3].

What the Evidence Says About Finasteride for Hair Loss

Finasteride 1 mg works by inhibiting type II 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). DHT is the primary androgen responsible for follicular miniaturization in male pattern baldness. Reducing scalp DHT levels by approximately 64% slows or reverses hair thinning in most men [4].

Landmark Clinical Trial Data

The key trial that supported FDA approval enrolled 1,553 men aged 18 to 41 with mild to moderate vertex hair loss. At 2 years, 83% of men taking finasteride 1 mg daily maintained or increased hair count compared to 28% on placebo. Mean hair count increased by 138 hairs per 1-inch circle in the finasteride group versus a loss of 38 hairs in the placebo group [5]. That is a net difference of 176 hairs in a defined target area.

Long-Term Efficacy

A 5-year extension of the original trial (N=1,215) demonstrated durability of response, with finasteride-treated men maintaining improvements at year 5 while placebo-treated men continued to lose hair [6]. The Endocrine Society notes that finasteride and minoxidil remain the only two FDA-approved pharmacotherapies for male androgenetic alopecia, and clinical guidelines from the American Academy of Dermatology support finasteride as a first-line oral option [7].

Safety Profile

The most commonly reported adverse effects in clinical trials were decreased libido (1.8% vs. 1.3% placebo), erectile dysfunction (1.3% vs. 0.7% placebo), and decreased ejaculate volume (0.8% vs. 0.4% placebo) [5]. These resolved in most men who discontinued treatment and also resolved in 58% of men who continued treatment through the study. Post-marketing reports of persistent sexual side effects exist, and the FDA added warnings to the label in 2012, though the incidence and causality of persistent effects remain debated in the literature [8].

How to Check Your Specific WellCare Plan

WellCare operates dozens of different plan designs. Coverage details vary by state, plan type (Medicare Advantage, D-SNP, Medicaid, marketplace), and plan year. Relying on general statements about WellCare coverage without checking your specific plan could lead to surprises at the pharmacy.

Step-by-Step Formulary Check

Search for your plan's formulary on the WellCare website by entering your plan name or member ID. Look for finasteride in the formulary drug list and note whether the listed strength is 1 mg or 5 mg. The 5 mg strength for BPH will typically appear; the 1 mg strength for hair loss will typically be absent or listed under exclusions.

Calling Member Services

If the formulary search is unclear, call the number on the back of your WellCare member ID card. Ask specifically: "Is finasteride 1 mg covered for androgenetic alopecia under my plan's prescription drug benefit?" Document the representative's name, the date, and the reference number for the call.

Understanding Your Evidence of Coverage

Every WellCare plan issues an Evidence of Coverage (EOC) document annually. Section 5 of the EOC lists excluded drugs and categories. For most WellCare plans, "drugs used for cosmetic purposes or hair growth" appears in this section. This is the binding legal document for coverage disputes, so keeping a copy matters.

Formulary Exception Requests and Appeals

Even when a drug is excluded from a formulary, WellCare members have the right to request a coverage exception under Medicare Part D regulations. Success rates for cosmetic exclusion overrides are low, but the process exists.

How the Exception Process Works

Your prescribing physician must submit a written statement explaining why the excluded drug is medically necessary for your condition. For Propecia, this is a high bar because CMS specifically permits plans to exclude cosmetic and hair growth agents. The exception must demonstrate that no covered alternative exists for a medical (not cosmetic) condition [9].

When Exceptions Have a Better Chance

If hair loss is secondary to a documented medical condition (for example, scarring alopecia, alopecia related to an autoimmune disorder, or hair loss from chemotherapy), framing the exception around the underlying medical diagnosis rather than androgenetic alopecia may improve the odds. This is a conversation to have with your prescriber.

The Independent Review Entity

If WellCare denies a standard exception request, members can request an expedited or standard appeal. If the internal appeal is also denied, Medicare beneficiaries have the right to an independent review entity (IRE) determination. The IRE is a CMS-contracted third party that reviews the denial de novo [10].

Cost-Saving Alternatives When WellCare Won't Cover Propecia

Because WellCare and most other insurance plans exclude finasteride 1 mg for hair loss, most men pay out of pocket. The good news: generic finasteride 1 mg is one of the least expensive prescription medications in the U.S.

Generic Finasteride Cash Pricing

A 30-day supply of generic finasteride 1 mg ranges from $8 to $30 at most retail pharmacies without insurance. Using a pharmacy discount program (such as those available at major chain pharmacies) can bring the cost to the lower end of that range. A 90-day supply through mail-order pharmacies often costs $15 to $45 total [11].

Pill Splitting With Finasteride 5 mg

Some physicians prescribe finasteride 5 mg (which is covered by WellCare for BPH when diagnosed) and instruct patients to quarter the tablets. A quartered 5 mg tablet yields approximately 1.25 mg, close to the 1 mg hair loss dose. This approach requires a documented BPH diagnosis and physician supervision. Studies suggest that finasteride doses between 1 mg and 5 mg produce similar DHT suppression, with diminishing returns above 1 mg [12]. This is an off-label strategy that should only be pursued under medical guidance.

Manufacturer Programs and Online Pharmacies

Merck, the original manufacturer of Propecia, discontinued most direct patient assistance programs for the brand-name product after generic entry in 2006. Online telehealth platforms now offer finasteride 1 mg prescriptions with included pharmacy services, typically at $15 to $45 per month depending on the platform and whether additional products are bundled.

Topical Finasteride

Compounded topical finasteride (typically 0.1% to 0.25% solution) is an emerging alternative. A randomized controlled trial published in the Journal of the American Academy of Dermatology found that topical finasteride 0.25% applied daily produced hair count increases comparable to oral finasteride 1 mg while resulting in lower serum DHT suppression (34% vs. 55.6%), which may reduce systemic side effects [13]. Topical formulations are not covered by WellCare and are typically available through compounding pharmacies at $30 to $80 per month.

Finasteride 5 mg for BPH: A Different Coverage Story

WellCare's formulary treatment of finasteride changes entirely when the diagnosis is BPH rather than hair loss. Understanding this distinction matters for men who have both conditions.

BPH Indication and Coverage

Finasteride 5 mg received FDA approval for BPH in 1992, five years before the 1 mg hair loss indication. The PLESS trial (N=3,040) demonstrated that finasteride 5 mg reduced the risk of acute urinary retention by 57% and the need for BPH-related surgery by 55% over 4 years compared to placebo [14]. Based on this evidence, WellCare includes finasteride 5 mg on preferred generic tiers for the BPH indication.

Dual Benefit for Men With Both Conditions

Men diagnosed with both BPH and androgenetic alopecia who take finasteride 5 mg for the urological indication will likely experience hair growth benefits as a secondary effect. The American Urological Association guidelines recommend finasteride 5 mg as a first-line pharmacotherapy for men with moderate to severe BPH symptoms and prostate volume greater than 30 mL [15]. If your physician documents a BPH diagnosis, WellCare coverage for finasteride 5 mg becomes a standard formulary benefit.

How WellCare Compares to Other Insurers

WellCare's exclusion of Propecia and finasteride 1 mg for hair loss is the industry norm, not an outlier.

Medicare Part D Plans

Among the roughly 800 standalone Part D plans and 3,900 Medicare Advantage Prescription Drug (MA-PD) plans available in 2025, virtually all exclude hair growth agents from formulary coverage. CMS data shows that this exclusion category is one of the most uniformly applied across plan sponsors [1].

Employer-Sponsored and Commercial Plans

Some employer-sponsored commercial plans do cover finasteride 1 mg for hair loss, though this is becoming less common as employers tighten formulary management. A 2023 analysis by the Pharmacy Benefit Management Institute found that approximately 18% of large employer plans covered at least one hair loss medication under the pharmacy benefit, down from 26% in 2018 [16].

Medicaid Plans

WellCare's Medicaid managed care plans follow state-specific Medicaid formularies. Most state Medicaid programs exclude hair growth agents, though a few states cover finasteride 1 mg with prior authorization for specific diagnoses. Checking your state's preferred drug list is the definitive step.

What to Discuss With Your Doctor

A conversation with your prescriber should cover three questions. First, is finasteride 1 mg the right treatment for your specific pattern and severity of hair loss? The Norwood-Hamilton scale classifies male pattern baldness into seven stages, and finasteride is most effective in stages II through V [17]. Second, do you have any concurrent diagnoses (particularly BPH or lower urinary tract symptoms) that would make finasteride 5 mg a covered alternative? Third, are you willing to pay out of pocket at $8 to $30 per month for generic finasteride 1 mg, or would you prefer to explore other options like topical minoxidil 5%, which is available over the counter for approximately $10 to $25 per month?

For men starting finasteride, the FDA label recommends a baseline PSA measurement before initiating therapy, as finasteride reduces PSA levels by approximately 50% after 6 months of use, which can affect prostate cancer screening interpretation [18].